Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/29/2026 | PUT | $730.00 | 936 | +919 | +5,405.88% |
| 09/18/2026 | CALL | $1,400.00 | 612 | +495 | +423.08% |
| 05/22/2026 | PUT | $660.00 | 580 | +478 | +468.63% |
| 05/22/2026 | CALL | $1,050.00 | 743 | +363 | +95.53% |
| 05/22/2026 | PUT | $730.00 | 372 | +343 | +1,182.76% |
| 05/22/2026 | CALL | $1,220.00 | 344 | +296 | +616.67% |
| 06/18/2026 | CALL | $1,200.00 | 1,390 | -38 | -2.66% |
| 06/18/2026 | PUT | $700.00 | 1,259 | -38 | -2.93% |
| 06/18/2026 | PUT | $730.00 | 385 | -39 | -9.20% |
| 06/18/2026 | CALL | $1,000.00 | 2,153 | -55 | -2.49% |
| 06/18/2026 | CALL | $1,010.00 | 481 | -59 | -10.93% |
| 06/18/2026 | CALL | $1,360.00 | 360 | -96 | -21.05% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report
05/19 01:37 pm
Benzinga
Read moreEli Lilly Stock: Next Stop $2,000?
05/18 06:30 pm
The Motley Fool
Read moreSupreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case
05/18 01:42 pm
Benzinga
Read moreSitryx to Participate in Upcoming Investor Conferences
05/18 07:00 am
GlobeNewswire Inc.
Read moreIs Kailera Therapeutics a Buy After Its Sizzling IPO?
05/16 10:30 am
The Motley Fool
Read moreMy Top 3 Healthcare Stocks for May 2026
05/15 08:33 am
The Motley Fool
Read moreOligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight
05/14 01:00 pm
GlobeNewswire Inc.
Read moreWhy Doximity Stock Plunged Today
05/14 11:03 am
The Motley Fool
Read moreShould Eli Lilly Investors Worry About Its Newest Rival -- From Within?
05/14 05:05 am
The Motley Fool
Read moreIs Novo Nordisk's Rebound for Real--or Just a Head Fake?
05/13 01:15 pm
The Motley Fool
Read moreGlobal AI in Life Sciences Market Gearing Up for Outstanding Expansion at a CAGR of ~20% by 2034 | DelveInsight
05/13 01:00 pm
GlobeNewswire Inc.
Read moreGlobal Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight
05/13 01:00 pm
GlobeNewswire Inc.
Read moreEli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss
05/13 11:33 am
Benzinga
Read moreFirst-in-Class Oral PKM2 Modulator SYX-5219 Phase 1a Trial Data to be Presented at SID 2026
05/13 07:00 am
GlobeNewswire Inc.
Read moreWhy Hims & Hers Health Stock Just Crashed
05/12 11:32 am
The Motley Fool
Read moreRoche, Eli Lilly Alzheimer's Blood Test Cleared In Europe For Earlier Detection
05/12 10:07 am
Benzinga
Read moreIncome or Growth: Which Healthcare Stock Fits Your Portfolio Right Now?
05/11 03:30 pm
The Motley Fool
Read moreNxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
05/11 02:35 am
GlobeNewswire Inc.
Read moreWill Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
05/08 09:30 am
The Motley Fool
Read moreNarrow Tech Leadership Continues as Oil and Rates Fall
05/07 02:43 am
Investing.com
Read moreWegovy Pill Debut 'Fattens' Novo Nordisk's Profit Outlook
05/06 07:43 am
Benzinga
Read moreEli Lilly Advances As Inflammatory Bowel Disease Drug Reinforces Long-Term Confidence
05/05 10:55 am
Benzinga
Read more3 Reasons It's Not Too Late to Buy Eli Lilly Stock
05/04 08:30 pm
The Motley Fool
Read moreIs Eli Lilly Stock Heading for $1,000?
05/04 05:30 pm
The Motley Fool
Read moreLilly declares second-quarter 2026 dividend
05/04 11:11 am
Benzinga
Read morePfizer Stock: Still Priced Like It's Dead Money
05/03 07:15 pm
The Motley Fool
Read more$9 Trillion Is Pouring Into American Manufacturing — And It’s Just Getting Started
05/03 06:00 pm
GlobeNewswire Inc.
Read moreLilly’s Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
05/01 02:45 pm
Investing.com
Read moreDeal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy
05/01 02:35 pm
Benzinga
Read moreStock Market Today: Dow, S&P 500, Nasdaq Futures RiseAs Trump Administration Evades War Powers Deadline— Apple, Twilio, Roblox In Focus (UPDATED)
05/01 08:41 am
Benzinga
Read moreNxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
05/01 02:36 am
GlobeNewswire Inc.
Read moreStock Market Today: Dow Jones Roars As Industrials Rescue Wall Street From Meta-Led Tech Slide
04/30 01:09 pm
Benzinga
Read moreEli Lilly Raises 2026 Outlook On Strong Mounjaro And Zepbound Demand
04/30 12:03 pm
Benzinga
Read moreWhat's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
04/30 05:10 am
The Motley Fool
Read moreRetatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
04/29 11:00 am
GlobeNewswire Inc.
Read moreIs Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So
04/28 06:15 pm
The Motley Fool
Read moreRheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape
04/28 01:00 pm
GlobeNewswire Inc.
Read moreIs This Deal a Game Changer for Novo Nordisk?
04/27 08:30 pm
The Motley Fool
Read moreForget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli Lilly
04/27 08:15 pm
The Motley Fool
Read moreMag 7 Earnings Bonanza, Fed Await Stocks at Record Highs: What to Expect
04/27 05:36 am
Investing.com
Read moreIs SpaceX Really Worth $1.75 Trillion -- or Is That Actually Too Low?
04/27 05:11 am
The Motley Fool
Read moreThis Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street
04/26 10:02 am
The Motley Fool
Read moreShould You Add a Healthcare Stock to Your Portfolio This Month? And Should It Be Eli Lilly (LLY)?
04/25 07:05 pm
The Motley Fool
Read moreIs This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom?
04/25 01:05 pm
The Motley Fool
Read moreWhy Eli Lilly Stock Flopped on Friday
04/24 06:30 pm
The Motley Fool
Read moreDeal Dispatch: QXO Nabs TopBuild For $17 Million, Voya Financial Urged To Evaluate Strategic Options, Pat McGrath Exits Chapter 11
04/24 02:27 pm
Benzinga
Read moreRadiopharmaceuticals Market Size to Exceed USD 15.21 Billion By 2035 Rising Cancer Cases Boost the Market Demand
04/24 09:57 am
GlobeNewswire Inc.
Read more